Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
  1. 4 Open-market sale 10% owner sold 3,566 shares at $14.26 ($50,844)
  2. 4 Open-market sale 10% owner sold 48,472 shares at an average $14.32 ($694,194)
  3. 4 Open-market sale President and CEO sold 16,000 shares at an average $13.77 ($220,240)
  4. 4 Open-market sale Chief Operating Officer sold 9,000 shares at an average $14.01 ($126,100)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale 10% owner sold 1,120 shares at $14.27 ($15,982)
  11. 4 Open-market sale 10% owner sold 20,696 shares at $14.20 ($293,883)
  12. 4 Open-market sale 10% owner sold 27,875 shares at $14.20 ($395,825)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Financial Officer sold 4,567 shares at $13.00 ($59,371)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Financial Officer sold 2,258 shares at $11.45 ($25,854)
  19. 4 Open-market sale 10% owner sold 49,141 shares at $14.50 ($712,545)
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 212 filings